Total Payments
$7,155
2024 Payments
$110.10
Companies
9
Transactions
14
Medicare Patients
8,168
Medicare Billing
$3.1M
Payment Breakdown by Category
Other$4,825 (67.4%)
Consulting$1,000 (14.0%)
Travel$779.97 (10.9%)
Food & Beverage$537.66 (7.5%)
Education$11.92 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,825 | 1 | 67.4% |
| Consulting Fee | $1,000 | 1 | 14.0% |
| Travel and Lodging | $779.97 | 2 | 10.9% |
| Food and Beverage | $537.66 | 9 | 7.5% |
| Education | $11.92 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seattle Genetics, Inc. | $5,692 | 5 | $0 (2019) |
| Puma Biotechnology, Inc. | $1,117 | 2 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $100.80 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $88.36 | 1 | $0 (2024) |
| Foundation Medicine, Inc. | $83.15 | 1 | $0 (2018) |
| Daiichi Sankyo Inc. | $22.17 | 1 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $21.74 | 1 | $0 (2024) |
| Genentech USA, Inc. | $17.34 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.10 | 2 | Regeneron Healthcare Solutions, Inc. ($88.36) |
| 2023 | $100.80 | 1 | Jazz Pharmaceuticals Inc. ($100.80) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $6,849 | 9 | Seattle Genetics, Inc. ($5,692) |
| 2018 | $83.15 | 1 | Foundation Medicine, Inc. ($83.15) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $88.36 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2023 | Jazz Pharmaceuticals Inc. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 10/22/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Anemia | ||||||
| 10/08/2019 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ, ROZLYTREK | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: BioOncology | ||||||
| 05/09/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $117.11 | General |
| Category: Oncology | ||||||
| 03/29/2019 | Seattle Genetics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,825.00 | General |
| 03/15/2019 | Seattle Genetics, Inc. | — | Travel and Lodging | In-kind items and services | $498.60 | General |
| 03/15/2019 | Seattle Genetics, Inc. | — | Travel and Lodging | In-kind items and services | $281.37 | General |
| 03/15/2019 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $56.99 | General |
| 03/15/2019 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 11/08/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $83.15 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 1,995 | 41,178 | $3.5M | $1.3M |
| 2022 | 52 | 2,030 | 28,443 | $1.9M | $558,031 |
| 2021 | 54 | 1,987 | 32,407 | $1.9M | $605,452 |
| 2020 | 59 | 2,156 | 44,064 | $2.0M | $683,239 |
Total Patients
8,168
Total Services
146,092
Medicare Billing
$3.1M
Procedure Codes
215
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 20 | 16,600 | $1.9M | $713,872 | 38.0% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2023 | 14 | 9,180 | $901,935 | $336,750 | 37.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 2,340 | $113,490 | $42,692 | 37.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 130 | 258 | $111,230 | $34,805 | 31.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 75 | 209 | $89,975 | $21,579 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 221 | $68,228 | $20,544 | 30.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 90 | $67,770 | $10,997 | 16.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 36 | 43 | $40,872 | $9,479 | 23.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 30 | 115 | $27,744 | $6,861 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $21,007 | $6,395 | 30.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 175 | 725 | $12,688 | $5,366 | 42.3% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 47 | 56 | $32,088 | $5,347 | 16.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 167 | 637 | $9,102 | $5,018 | 55.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 140 | 445 | $9,901 | $4,490 | 45.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 52 | 175 | $16,319 | $3,974 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 55 | $11,976 | $3,613 | 30.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 37 | 66 | $14,322 | $3,387 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $13,515 | $3,342 | 24.7% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 17 | 46 | $9,580 | $2,341 | 24.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 24 | $6,804 | $2,196 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 61 | 125 | $7,719 | $1,387 | 18.0% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 11 | 13 | $5,922 | $1,094 | 18.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 25 | 63 | $2,599 | $1,045 | 40.2% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 35 | 101 | $2,121 | $913.51 | 43.1% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 15 | 34 | $4,760 | $896.09 | 18.8% |
About Dr. Yoshio Inoue, M.D
Dr. Yoshio Inoue, M.D is a Internal Medicine healthcare provider based in Everett, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891748331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yoshio Inoue, M.D has received a total of $7,155 in payments from pharmaceutical and medical device companies, with $110.10 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,825).
As a Medicare-enrolled provider, Inoue has provided services to 8,168 Medicare beneficiaries, totaling 146,092 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Everett, WA
- Active Since 05/18/2006
- Last Updated 07/31/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891748331
Products in Payments
- Nerlynx (Drug) $1,117
- DEFITELIO (Drug) $100.80
- LIBTAYO (Biological) $88.36
- FOUNDATIONONE (Device) $83.15
- INJECTAFER (Drug) $22.17
- MYRISK (Device) $21.74
- Alecensa (Biological) $17.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Everett
Dr. Conrad Jablonski, Md, MD
Internal Medicine — Payments: $53,897
Internal Medicine $53,897
Ricardo Cardona Guarache, M.d, M.D
Internal Medicine — Payments: $25,669
Internal Medicine $25,669
Deepak Thatai, Md, MD
Internal Medicine — Payments: $18,399
Internal Medicine $18,399
Dr. Irina Milman, Md, MD
Internal Medicine — Payments: $6,747
Internal Medicine $6,747
Dr. Meng Zhao, M.d, M.D
Internal Medicine — Payments: $3,477
Internal Medicine $3,477
Dr. James Liadis, M.d, M.D
Internal Medicine — Payments: $3,449
Internal Medicine $3,449